Changeflow GovPing Healthcare Sanofi-Aventis resettable medication delivery d...
Routine Notice Added Final

Sanofi-Aventis resettable medication delivery drive mechanism patent

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Medical Devices (A61M)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent EP3536364A1 for Sanofi-Aventis Deutschland GmbH covering a resettable drive mechanism for medication delivery devices. The patent, filed by inventors NZIKE, RAAB, BRÜGGEMANN, DASBACH, and BOESER, provides IP protection across 24 designated EU member states.

What changed

Sanofi-Aventis Deutschland GmbH was granted European Patent EP3536364A1 for a resettable drive mechanism for medication delivery devices. The invention falls under IPC classifications A61M 5/315 and A61M 5/24, covering injection and infusion device technologies. The patent is designated for protection across 24 EU states including Germany, France, United Kingdom, Italy, and Spain.

Pharmaceutical and medical device companies developing drug delivery systems should review this patent to ensure their products do not infringe on the protected resettable drive mechanism technology. R&D teams should conduct freedom-to-operate analyses for any injection or infusion devices under development. Legal departments should update IP monitoring protocols to track potential licensing opportunities or design-around requirements.

What to do next

  1. Review patent EP3536364A1 claims to assess potential infringement on resettable medication delivery mechanisms
  2. Conduct freedom-to-operate analysis for drug delivery devices in development
  3. Update IP monitoring protocols to track related patent applications in the A61M classification

Source document (simplified)

← EPO Patent Bulletin

RESETTABLE DRIVE MECHANISM FOR A MEDICATION DELIVERY DEVICE AND MEDICATION DELIVERY DEVICE

Publication EP3536364A1 Kind: A1 Mar 25, 2026

Applicants

Sanofi-Aventis Deutschland GmbH

Inventors

NZIKE, Philippe, RAAB, Steffen, BRÜGGEMANN, Ulrich, DASBACH, Uwe, BOESER, Uwe

IPC Classifications

A61M 5/315 20060101AFI20260219BHEP A61M 5/24 20060101ALN20260219BHEP

Designated States

AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR

View original document →

Named provisions

Resettabl

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3536364A1

Who this affects

Applies to
Medical device makers Pharmaceutical companies Healthcare providers
Industry sector
3345 Medical Device Manufacturing 3254 Pharmaceutical Manufacturing 6211 Healthcare Providers
Activity scope
Patent Grant Medical Device IP Drug Delivery Technology
Geographic scope
European Union EU

Taxonomy

Primary area
Medical Devices
Operational domain
Legal
Topics
Intellectual Property Pharmaceuticals Healthcare

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Medical Devices (A61M) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.